- Report
- March 2024
- 199 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1206EUR$1,250USD£1,035GBP
- Report
- July 2023
- 129 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- July 2023
- 65 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- October 2023
- 182 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- December 2023
- 159 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- April 2024
- 174 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- March 2024
- 148 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- October 2023
- 145 Pages
Global
From €3040EUR$3,150USD£2,608GBP
- Report
- July 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- March 2023
- 68 Pages
Global
From €3373EUR$3,495USD£2,894GBP
- Report
- February 2024
- 85 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Drug Pipelines
- March 2021
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- July 2020
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- May 2023
- 160 Pages
Global
From €5790EUR$5,999USD£4,967GBP
Obsessive Compulsive Disorder (OCD) is a mental disorder characterized by intrusive thoughts that produce anxiety, and by repetitive behaviors aimed at reducing that anxiety. OCD is treated with a combination of psychotherapy and medication. Drugs used to treat OCD include selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and monoamine oxidase inhibitors (MAOIs). SSRIs are the most commonly prescribed medications for OCD, as they are generally well-tolerated and have fewer side effects than other medications.
The OCD drug market is highly competitive, with a number of major pharmaceutical companies offering products. These include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Other companies, such as Lundbeck, Otsuka, and Sunovion, also offer products for the treatment of OCD. Show Less Read more